glp-1 receptor agonists blindness risk Eye doctors warn drugs for diabetes and weight loss may pose rare vision risks, recommending regular checkups Repurposing glucagon-like peptide-1 receptor agonists

Dan Med J

RAGE: receptor AGE

Patients, and that's really what this is all about," Stevens said, adding that being the second small molecule drug will be important

In the same trial, tirzepatide and semaglutide were compared once weekly in the open-label, phase III SURPASS-2 experiment

December 2, 2025: Australia Regulators Add Risk of Suicidal, Self-Harm Thoughts to Trulicity Label Patients who took Trulicity have reported experiencing thoughts of harming themselves or ending their lives, the Therapeutic Goods Administration warns

The influence of SGLT2 inhibitors, dipeptidyl peptidase IV (DPP-4) inhibitors, and sulfonylureas on cancer risk remains inconclusive